La Jolla's low blood pressure treatment clears key study

(Reuters) - La Jolla Pharmaceutical Co said on Monday its lead experimental drug to treat low blood pressure met the main goal of a late-stage study on patients with distributive shock who had not adequately responded to existing treatments.

Source: Reuters: Health - February 27, 2017 Category: Consumer Health News Tags: healthNews Source Type: news